Sign In
Buy PBH
$45.44
-0.390 (-0.85%)
At Close: Jun 03, 2026
Prestige Consumer Q4 EPS $0.820 Beats $0.740 Estimate, Sales $251.235M Beat $239.840M Estimate
10:52am, Thursday, 07'th May 2020Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Fourth Quarter and Full-Year Results
10:00am, Thursday, 07'th May 2020
Revenue was $251.2 Million in Q4 and $963.0 Million in Full-Year Fiscal 2020Organic Revenue Grew 4.6% in Q4 and 1.3% in Fiscal 2020Generated Cash from Operations of $217.1.
Karuna Therapeutics Reports First Quarter 2020 Financial Results and Provides General Business Update
12:00am, Thursday, 07'th May 2020
Karuna Therapeutics, Inc. (Nasdaq: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the pote
The allergy rhinitis drugs market size has the potential to grow by USD 2.4 billion during 2020-2024
Ipsen enters into an option agreement with IRICoR and Université de Montréal for a discovery-stage oncology program
12:00am, Monday, 04'th May 2020
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, IRICoR, a pan-Canadian research commercializati
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
04:34pm, Thursday, 30'th Apr 2020
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
04:34pm, Thursday, 30'th Apr 2020
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks: Analysts Expect Prestige Consumer Healthcare Inc (NYSE:PBH) to Announce $0.74 Earnings Per Share
10:36am, Thursday, 30'th Apr 2020
Wall Street brokerages expect Prestige Consumer Healthcare Inc (NYSE:PBH) to announce $0.74 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Four analysts ha
Prestige Consumer Healthcare Inc (NYSE:PBH) Stake Lifted by BBVA USA Bancshares Inc.
09:06am, Thursday, 30'th Apr 2020
BBVA USA Bancshares Inc. lifted its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 64.1% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The instit
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
12:00am, Thursday, 30'th Apr 2020Helen of Troy (HELE) Stock Up as Q4 Earnings & Sales Rise Y/Y
02:30pm, Wednesday, 29'th Apr 2020
Helen of Troy's (HELE) Q4 results benefit from increased demand for certain products along with double-digit growth in all three business segments
PFIZER Reports First-Quarter 2020 Results | STL.News
01:16pm, Tuesday, 28'th Apr 2020
PFIZER Reports First-Quarter 2020 Results | STL.News | Read business news and more at STL.News. Please share.
Sanofi Q1 2020 Earnings Call Key Takeaways
07:58pm, Monday, 27'th Apr 2020
We highlight main points from the SNY Q1 conference call and summarize key takeaways for investors. Q1 results were strong overall, but taking away COVID-19 add
Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Fourth Quarter and Year-End Earnings Results
12:00pm, Monday, 27'th Apr 2020
TARRYTOWN, N.Y., April 27, 2020 -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 fourth quarter and year-end earnings release.
Prestige Consumer Healthcare Inc (NYSE:PBH) Shares Sold by Ladenburg Thalmann Financial Services Inc.
09:06am, Saturday, 25'th Apr 2020
Ladenburg Thalmann Financial Services Inc. lessened its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 24.1% during the 4th quarter, according to the company in its most recent 13F filing
